IL ‐25 Improves MAFLD by Suppressing the Notch Signalling in Hepatic Macrophages

These findings suggest a role for IL-25 in modulating macrophage polarisation and inflammation in metabolic dysfunction-associated fatty liver disease, supporting its further exploration as a potential therapeutic strategy for inflammatory liver diseases.